Minerva Neurosciences
NERV
NERV
68 hedge funds and large institutions have $63.2M invested in Minerva Neurosciences in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less capital invested
Capital invested by funds: $92.9M → $63.2M (-$29.7M)
35% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 26
Holders
68
Holding in Top 10
–
Calls
$964K
Puts
$356K
Top Buyers
| 1 | +$1.68M | |
| 2 | +$1.31M | |
| 3 | +$597K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$577K |
| 5 |
D.E. Shaw & Co
New York
|
+$521K |
Top Sellers
| 1 | -$4.47M | |
| 2 | -$2M | |
| 3 | -$1.65M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.07M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$893K |